NCT00045955View on ClinicalTrials.gov

Long-Term Safety Performance of Fexofenadine in Asthma

PHASE3CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions

Asthma

Interventions

DRUG

Fexofenadine, Comparator = Montelukast

Trial Locations (1)

08807

Aventis Pharmaceutical Inc., Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY